Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with disease modifying therapies

被引：0
|
作者：
Barone, S. [1 ]
Palmieri, C. [2 ]
Gallelli, L. [3 ]
Rania, V. [3 ]
Bruno, P. A. [1 ]
Pasquale, M. [1 ]
Pascarella, A. [1 ]
Manzo, L. [1 ]
De Sarro, G. [3 ]
Gambardella, A. [1 ]
Valentino, P. [1 ]
机构：
[1] Magna Graecia Univ Catanzaro, Inst Neurol, Dept Med & Surg Sci, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Clin Biochem & Cell Biol, Biochem Lab, Dept Expt & Clin Med, Catanzaro, Italy
[3] Magna Graecia Univ Catanzaro, Clin Pharmacol Unit, Dept Hlth Sci, Sch Med, Catanzaro, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1091
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [1] Humoral response to SARS-CoV-2-mRNA vaccine in multiple sclerosis patients treated with high efficacy disease-modifying therapies
    Capuano, R.
    Donnarumma, G.
    Bisecco, A.
    Grimaldi, E.
    Conte, M.
    d'Ambrosio, A.
    Matrone, F.
    Risi, M.
    Giuliano, F.
    Borgo, R.
    Altieri, M.
    Coppola, N.
    Galdiero, M.
    Tedeschi, G.
    Gallo, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 561 - 562
  • [2] Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
    Capuano, Rocco
    Donnarumma, Giovanna
    Bisecco, Alvino
    Grimaldi, Elena
    Conte, Miriana
    d'Ambrosio, Alessandro
    Matrone, Federica
    Risi, Mario
    Borgo, Riccardo Maria
    Altieri, Manuela
    Giuliano, Federica
    Coppola, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    Gallo, Antonio
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [3] Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables
    Barone, Stefania
    Palmieri, Camillo
    Gallelli, Luca
    Rania, Vincenzo
    Pascarella, Angelo
    Abatino, Antonio
    Bruno, Pietro Antonio
    Casarella, Alessandro
    Pasquale, Marilisa
    Manzo, Lucia
    De Sarro, Giovambattista
    Gambardella, Antonio
    Valentino, Paola
    NEUROTHERAPEUTICS, 2024, 21 (02)
  • [4] Effect of SARS-CoV-2 mRNA vaccination in multiple sclerosis patients treated with disease modifying therapies
    Sormani, M. P.
    Inglese, M.
    Schiavetti, I.
    Carmisciano, L.
    Laroni, A.
    Lapucci, C.
    Da Rin, G.
    Serrati, C.
    Gandoglia, I.
    Tassinari, T.
    Perego, G.
    Brichetto, G.
    Gazzola, P.
    Mannironi, A.
    Stromillo, M. L.
    Cordioli, C.
    Landi, D.
    Clerico, M.
    Signoriello, E.
    Frau, J.
    Ferro, M. T.
    Di Sapio, A.
    Pasquali, L.
    Ulivelli, M.
    Marinelli, F.
    Callari, G.
    Iodice, R.
    Liberatore, G.
    Caleri, F.
    Repice, A. M.
    Cordera, S.
    Battaglia, M. A.
    Salvetti, M.
    Franciotta, D.
    Uccelli, A.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 743 - 744
  • [5] Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab
    Brill, Livnat
    Rechtman, Ariel
    Zveik, Omri
    Haham, Nitzan
    Oiknine-Djian, Esther
    Wolf, Dana G.
    Levin, Netta
    Raposo, Catarina
    Vaknin-Dembinsky, Adi
    JAMA NEUROLOGY, 2021, 78 (12) : 1510 - 1514
  • [6] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    Allman, M.
    Tallantyre, E.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 2259 - 2261
  • [7] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    M. Allman
    E. Tallantyre
    N. P. Robertson
    Journal of Neurology, 2022, 269 : 2259 - 2261
  • [8] Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
    Katz, J.
    Bouley, A.
    Lathi, E.
    Douglas, E.
    Jungquist, R. -M.
    O'Shea, I.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 786 - 787
  • [9] Humoral and T-cell responses to SARS-CoV-2 vaccination in multiple sclerosis patients treated with ocrelizumab
    Katz, J. D.
    Bouley, A. J.
    Jungquist, R. M.
    Douglas, E. A.
    O'Shea, I. L.
    Lathi, E. S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [10] Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
    Gallo, Antonio
    Capuano, Rocco
    Donnarumma, Giovanna
    Bisecco, Alvino
    Grimaldi, Elena
    Conte, Miriana
    d'Ambrosio, Alessandro
    Coppola, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    NEUROLOGICAL SCIENCES, 2021, 42 (09) : 3523 - 3526
12345